NorthWest Healthcare Properties Real Estate Investment Trust Valuation
Is NWHU.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NWHU.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NWHU.F ($3.53) is trading below our estimate of fair value ($3.64)
Significantly Below Fair Value: NWHU.F is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NWHU.F?
Key metric: As NWHU.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is NWHU.F's PS Ratio? | |
|---|---|
| PS Ratio | 2.5x |
| Sales | CA$483.34m |
| Market Cap | CA$1.21b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 11x |
| Enterprise Value/EBITDA | 17x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NWHU.F's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.8x | ||
CHTH CNL Healthcare Properties | 1.8x | n/a | US$652.3m |
DHC Diversified Healthcare Trust | 0.4x | 5.3% | US$581.5m |
STRW Strawberry Fields REIT | 0.8x | 3.0% | US$656.3m |
GMRE Global Medical REIT | 4.3x | 3.2% | US$600.7m |
NWHU.F NorthWest Healthcare Properties Real Estate Investment Trust | 2.5x | -7.8% | US$1.2b |
Price-To-Sales vs Peers: NWHU.F is expensive based on its Price-To-Sales Ratio (2.5x) compared to the peer average (1.8x).
Price to Sales Ratio vs Industry
How does NWHU.F's PS Ratio compare vs other companies in the US Health Care REITs Industry?
Price-To-Sales vs Industry: NWHU.F is good value based on its Price-To-Sales Ratio (2.5x) compared to the US Health Care REITs industry average (5.6x).
Price to Sales Ratio vs Fair Ratio
What is NWHU.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.5x |
| Fair PS Ratio | 3.1x |
Price-To-Sales vs Fair Ratio: NWHU.F is good value based on its Price-To-Sales Ratio (2.5x) compared to the estimated Fair Price-To-Sales Ratio (3.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$3.53 | US$4.08 +15.9% | 7.3% | US$4.65 | US$3.76 | n/a | 6 |
| Nov ’25 | US$3.62 | US$4.28 +18.4% | 6.8% | US$4.74 | US$4.01 | n/a | 6 |
| Oct ’25 | US$4.19 | US$4.16 -0.6% | 7.3% | US$4.74 | US$3.83 | n/a | 6 |
| Sep ’25 | US$3.74 | US$4.16 +11.3% | 7.3% | US$4.74 | US$3.83 | n/a | 6 |
| Aug ’25 | US$3.66 | US$4.19 +14.6% | 7.1% | US$4.74 | US$3.83 | n/a | 6 |
| Jul ’25 | US$3.39 | US$4.25 +25.1% | 6.8% | US$4.77 | US$3.85 | n/a | 6 |
| Jun ’25 | US$3.66 | US$4.25 +16.1% | 6.8% | US$4.77 | US$3.85 | n/a | 6 |
| May ’25 | US$3.71 | US$4.12 +11.0% | 9.9% | US$4.83 | US$3.72 | n/a | 6 |
| Apr ’25 | US$3.38 | US$4.12 +21.8% | 9.9% | US$4.83 | US$3.72 | n/a | 6 |
| Mar ’25 | US$3.00 | US$4.12 +37.1% | 9.9% | US$4.83 | US$3.72 | n/a | 6 |
| Feb ’25 | US$3.68 | US$4.26 +15.9% | 8.9% | US$4.85 | US$3.73 | n/a | 6 |
| Jan ’25 | US$3.88 | US$4.09 +5.5% | 9.5% | US$4.75 | US$3.65 | n/a | 7 |
| Dec ’24 | US$3.37 | US$4.09 +21.5% | 9.5% | US$4.75 | US$3.65 | n/a | 7 |
| Nov ’24 | US$3.03 | US$4.60 +51.8% | 10.9% | US$5.46 | US$3.82 | US$3.62 | 7 |
| Oct ’24 | US$3.78 | US$5.05 +33.6% | 17.7% | US$6.63 | US$4.05 | US$4.19 | 7 |
| Sep ’24 | US$5.01 | US$6.17 +23.1% | 13.5% | US$7.01 | US$4.80 | US$3.74 | 7 |
| Aug ’24 | US$5.15 | US$6.77 +31.5% | 17.3% | US$8.34 | US$4.93 | US$3.66 | 7 |
| Jul ’24 | US$4.72 | US$6.99 +48.0% | 13.2% | US$8.34 | US$5.31 | US$3.39 | 7 |
| Jun ’24 | US$5.50 | US$7.77 +41.4% | 13.2% | US$9.63 | US$6.29 | US$3.66 | 7 |
| May ’24 | US$5.98 | US$7.91 +32.3% | 10.8% | US$9.60 | US$6.64 | US$3.71 | 7 |
| Apr ’24 | US$6.20 | US$8.98 +44.9% | 8.7% | US$9.99 | US$7.77 | US$3.38 | 7 |
| Mar ’24 | US$6.89 | US$9.28 +34.7% | 10.0% | US$10.46 | US$7.84 | US$3.00 | 7 |
| Feb ’24 | US$7.45 | US$9.28 +24.6% | 10.0% | US$10.46 | US$7.84 | US$3.68 | 7 |
| Jan ’24 | US$6.87 | US$9.74 +41.8% | 8.1% | US$10.41 | US$8.18 | US$3.88 | 7 |
| Dec ’23 | US$7.55 | US$9.74 +29.0% | 8.1% | US$10.41 | US$8.18 | US$3.37 | 7 |
| Nov ’23 | US$7.84 | US$10.34 +31.9% | 8.5% | US$11.39 | US$8.45 | US$3.03 | 7 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Innovative Industrial Properties
US$3.0b
A self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities.
IIPR
US$107.12
7D
4.8%
1Y
33.3%
Boardwalk Real Estate Investment Trust
CA$3.8b
Boardwalk REIT strives to be Canada's friendliest community provider and is a leading owner/operator of multi-family rental communities.
BOWF.F
CA$50.23
7D
2.0%
1Y
5.6%
NewLake Capital Partners
US$394.7m
An internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects.
NLCP
US$18.90
7D
3.2%
1Y
43.7%